Advances in computational biology celebrated by the Nobel Prize for Chemistry
Lola Bell reports on the journey of protein structure discovery leading to the awards for the 2024 Nobel Prize for Chemistry.
Edie Allden explores the artistic side of biochemistry and how ethics and access challenge the universality of BioArt.
Eloise Elkington explores the largely disputed origins of COVID-19 and how evidence suggests but not proves a wet market origin.
Waywen Loh discusses the daily cycle of our immune system and how this can be exploited during vaccination.
Matthew Rogers explores the green technology ocean thermal energy conversion, which could be better than conventional renewable energy.
Millicent Crewe discusses the recent rejection of MDMA-assisted therapy for PTSD and the impact on the world of therapy and psychedelics.
Satchel Walton reflects on why some people struggle to trust scientists in an ever-politicised field and how scientists should boost trust.
From stars to sacrifices: Jan Maciejewski reports on historical interpretations of solar eclipses and where they came from.
Arabella Fearnley-Whittingstall evaluates the sustainability and potential implications of biodesign, ranging from concrete to fashion.
Lola Bell reports on the journey of protein structure discovery leading to the awards for the 2024 Nobel Prize for Chemistry.
Faye Chang remarks on the issues with COP16’s biodiversity policy and reflects on how they can be improved.
Douglas Brown delves into why scientific papers can be so bland and dull and how scientists can improve their language.
Olivia Allen explores the realms of sustainable aviation and how hydrocarbons may fuel the future of air travel.
Faye Chang introduces the elusive COP16 and explores its role in helping to slow down the biodiversity crisis.
Ushika Kidd interviews Dr Jane Jin, COO of OXCCU, a climate-forward sustainable aviation fuels company based in Oxford.